Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth ▾	Diluted EPS
FBLG	FibroBiologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$18.65M	n/a	-302.9%	n/a	-$0.42
FLNA	Filana Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$90.97M	n/a	-122.3%	n/a	-$1.88
FTH	Faeth Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$21.09M	n/a	-113.4%	n/a	-$16.72
GALT	Galectin Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$30.84M	n/a	n/a	n/a	-$0.48
GANX	Gain Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$20.16M	n/a	-108.6%	n/a	-$0.61
GCAN	Trafalgar International, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$331.6K	n/a	n/a	n/a	$0.00
GERN	Geron Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$83.50M	n/a	-37.0%	n/a	-$0.13
GLSI	Greenwich LifeSciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.36M	n/a	n/m	n/a	-$1.43
GNPX	Genprex, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$16.23M	n/a	-203.8%	n/a	n/a
GPCR	Structure Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$141.20M	n/a	-9.3%	n/a	-$0.80
GRCE	Grace Therapeutics, Inc. Manufacturing · Year ended 2026-03-31 · USD	n/a	-$7.79M	n/a	-12.2%	n/a	-$0.47
GRI	GRI Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.96M	n/a	-199.0%	n/a	-$121.80
GTBP	GT Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$28.35M	n/a	-490.0%	n/a	-$6.68
HEPA	Hepion Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.28M	n/a	-310.3%	n/a	-$0.88
HOWL	Werewolf Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$60.82M	n/a	-245.2%	n/a	-$1.33
HURA	TuHURA Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$30.05M	n/a	-143.6%	n/a	-$0.63
HYPD	Hyperion Defi, Inc. Manufacturing · Year ended 2025-12-31 · USD	$813.5K	-$45.31M	n/m	-110.4%	n/m	-$9.40
IBO	Impact Biomedical Inc. Manufacturing · Year ended 2025-12-31 · USD	$32.0K	-$11.84M	n/m	-93.9%	n/a	-$0.38
IDYA	IDEAYA Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$218.71M	-$113.70M	-52.0%	-11.1%	n/m	-$1.28
IMMX	Immix Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$29.44M	n/a	-31.4%	n/a	-$0.89
IMNN	Imunon, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$14.50M	n/a	-205.3%	n/a	-$6.83
IMRX	Immuneering Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$56.02M	n/a	-25.6%	n/a	-$1.27
IMUX	Immunic, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$97.17M	n/a	n/a	n/a	-$0.62
INDP	Indaptus Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$20.85M	n/a	-661.5%	n/a	-$21.58
INM	InMed Pharmaceuticals Inc. Manufacturing · Year ended 2026-06-30 · USD	n/a	-$12.56M	n/a	n/m	n/a	-$3.12

Rows per page: 2550 100